Art

J-GLOBAL ID：201302262042520526   Reference number：13A0643492

Effect of Salt Intake on Bioavailability of Mizoribine in Healthy Japanese Males

健康な日本人男性におけるミゾリビンの生物学的利用能に対する食塩摂取の影響

Author (10)： ISHIDA Kazuya (Graduate School of Medicine and Pharmaceutical Sciences, Univ. of Toyama) ,  FUKAO Miki (Graduate School of Medicine and Pharmaceutical Sciences, Univ. of Toyama) ,  WATANABE Hitomi (Graduate School of Medicine and Pharmaceutical Sciences, Univ. of Toyama) ,  TAGUCHI Masato (Graduate School of Medicine and Pharmaceutical Sciences, Univ. of Toyama) ,  MIYAWAKI Toshio (Graduate School of Medicine and Pharmaceutical Sciences, Univ. of Toyama) ,  MATSUKURA Hiroyoshi (Dep. of Pediatrics, Saiseikai Toyama Hospital) ,  UEMURA Osamu (Dep. of Pediatric Nephrology, Aichi Children’s Health and Medical Center) ,  ZHANG Zufei (Dep. of Pharmaceutics, School of Pharmacy, Univ. of Washington) ,  UNADKAT Jashvant D. (Dep. of Pharmaceutics, School of Pharmacy, Univ. of Washington) ,  HASHIMOTO Yukiya (Graduate School of Medicine and Pharmaceutical Sciences, Univ. of Toyama)
Material： Drug Metabolism and Pharmacokinetics  (Drug Metab Pharmacokinet)
Volume： 28  Issue： 1  Page： 75-80 (J-STAGE)  Publication year： 2013 
JST Material Number： X0758A  ISSN： 1347-4367  Document type： Article
Article type： 短報  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： human ,...
Semi thesaurus term： *cell physiology ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=13A0643492&from=J-GLOBAL&jstjournalNo=X0758A") }}

JST classification (2)： Clinical biopharmacy  (GY01022L) ,  Cell physiology in general  (EF02010S)

Substance index (1)： Mizoribine

Reference (24)：

• 1. Yokota, S.: Mizoribine: mode of action and effects in clinical use. Pediatr. Int., 44:196−198 (2002).
• 2. Shibasaki, T., Koyama, A., Hishida, A., Muso, E., Osawa, G., Yamabe, H., Shiiki, H., Makino, H., Sato, H., Ishikawa, I., Maeda, K., Tomita, K., Arakawa, M., Ishida, M., Sato, M., Nagase, M., Kashihara, N., Yorioka, N., Koike, T., Saito, T., Harada, T., Mitarai, T., Sugisaki, T., Nagasawa, T., Tomino, Y., Nojima, Y., Kobayashi, Y., and Sakai, O.: A randomized open-label comparative study of conventional therapy versus mizoribine onlay therapy in patients with steroid-resistant nephrotic syndrome (postmarketing survey). Clin. Exp. Nephrol., 8:117−126 (2004).
• 3. Mizuno, K., Tsujino, M., Takada, M., Hayashi, M., Atsumi, K., Asano, K., and Matsuda, T.: Studies on Bredinin. I. Isolation, characterization and biological properties. J. Antibiot., 27:775−782 (1974).
• 4. Liu, D., Kobayashi, T., Nagasaka, T., Yokoyama, I., Ma, Y., Miwa, Y., Kazuya, T., Morozumi, K., Oikawa, T., Shimano, Y., Takeuchi, O., Uchida, K., and Nakao, A.: Potential value of high-dose mizoribine as rescue therapy for ongoing acute humoral rejection. Transpl. Int., 18:401−407 (2005).
• 5. Kusaba, R., Otubo, O., Inou, T., Tujino, M., and Ishikawa, H.: Studies on pharmacokinetics of bredinin. Jpn. J. Transplant., 17 (Suppl.):585−593 (1982). in Japanese.

Terms in the title (6)： 日本人 ,  男性 ,  ミゾリビン ,  生物学的利用能 ,  食塩 ,  摂取